The U.S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products from Schedule III to the more restrictive Schedule II. The rule goes into effect in 45 days. In 2013, a U. S. Food and Drug Administration Advisory Committee voted to recommend rescheduling these products
, and the U.S. Department of Health and Human Services sent a recommendation to DEA consistent with that vote.
Read the DEA’s press release.